The aim of the current review is to provide an overview of the current diagnostic and therapeutic approaches to central serous chorioretinopathy, pachychoroid spectrum diseases and choroidal neovascularization
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The aim of the current review is to provide an overview of the current diagnostic and therapeutic approaches to central serous chorioretinopathy, pachychoroid spectrum diseases and choroidal neovascularization
📊
Key Findings & Data:The aim of the current review is to provide an overview of the current diagnostic and therapeutic approaches to central serous chorioretinopathy, pachychoroid spectrum diseases and choroidal neovascularization
💡
Conclusion & Impact:The aim of the current review is to provide an overview of the current diagnostic and therapeutic approaches to central serous chorioretinopathy, pachychoroid spectrum diseases and choroidal neovascularization
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
The aim of the current review is to provide an overview of the current diagnostic and therapeutic approaches to central serous chorioretinopathy, pachychoroid spectrum diseases and choroidal neovascularization
Özet
Bu derlemede güncel literatür ışığında santral seröz koryoretinopati, pakikoroid spektrumu hastalıklar ve koroid neovaskülarizasyonların tanısında ve tedavisinde yeni gelişmelerin gözden geçirilmesi amaçlanmıştır
🔖
Cite This Article
ARF, S., HOCAOĞLU, M., ERSÖZ, M. G. (2017). Central Serous Chorioretinopathy, Pachychoroid Spectrum Diseases and. Güncel Retina Dergisi, Cilt: 1 - Sayı: 4, 289–295. https://ajindex.com/articles/224238
References (16)
Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013
58(2):103-26. 2.Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S. Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology. 2004
111(2):244-9 3.Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology 1996
103(12):2070–2080. 4.Lehmann M, Bousquet E, Beydoun T, Behar-Cohen F. Pachychoroıd: an inherited condition? Retina. 2015
35(1):10-6. 5.Nadel AJ, Turan MI, Coles RS: Central serous retinopathy. A generalized disease of the pigment epithelium. Mod Probl Opthalmol. 1979
Nadel AJ, Turan MI, Coles RS: Central serous retinopathy. A generalized disease of the pigment epithelium. Mod Probl Opthalmol. 1979
Marmar MF. New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1988
Spaide RF, Goldbaum M, Wong DW, Tang KC, Iida T. Serous detachment of the retina. Retina. 2003
23(6):820–46. 8.Tittl M, Polska E, Kircher K, et al. Topical fundus pulsation measurement in patients with active central serous chorioretinopathy. Arch Ophthalmol. 2003
121(7):975–8. 9.Yang L, Jonas JB, Wei W. Choroidal vessel diameter in central serous chorioretinopathy. Acta Ophthalmol 2013
91(5):358–362. 10.Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009
29(10): 1469–1473. 11.Klein ML, Van Buskirik EM, Freidmen E, et al. Experience with non-treatment of central serous choroidopathy. Arch Ophthalmol 1974
250 12.Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment. Int Ophthalmol 2017
37(3):483-489. 13.Spaide RF, Hall L, Haas A, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996
16(3):203– 213. 14. Loo RH, Scott IU, Flynn HW Jr, et al. Factors associated with reduced visual acuity during longterm follow-up of patients with idiopathic central serous chorioretinopathy. Retina 2002
22(1):19–24. 15.Daruich A, Matet A, Dirani A, et al. Central serous chorioretinopat